Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues.

Pathology - 1 Mar 2024

Wong Richard Wing-Cheuk, Cheung Annie N Y

Abstract excerpt

The evaluation of biomarkers by molecular techniques and immunohistochemistry has become increasingly relevant to the treatment of female genital tract tumours as a consequence of the greater availability of therapeutic options and updated disease classifications. For ovarian cancer, mutation testing for BRCA1/2 is the standard predictive biomarker for poly(ADP-ribose) polymerase inhibitor therapy, while...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Carcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Relevance

Share to DNA Mismatch Repair

Share to Endometrial Neoplasms

Share to Genitalia, Female

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 38212229
DOI: 10.1016/j.pathol.2023.10.013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues.PMID 38212229Read ↗

A review of reviews of the prevalence of molecular biomarkers in vulvar cancer and their implications for prognosis refinement and treatment strategies.Semantic proximity Read ↗

[Molecular diagnostic techniques in gynaecologic cancer].Semantic proximity Read ↗

The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer.Semantic proximity Read ↗

Molecular approaches for classifying endometrial carcinoma.Semantic proximity Read ↗

Diagnostic Accuracy of Immunohistochemistry for Mismatch Repair Proteins as Surrogate of Microsatellite Instability Molecular Testing in Endometrial CancerSemantic proximity Read ↗

Biomarker assessment and molecular testing for prognostication in breast cancerSemantic proximity Read ↗

Assessment of immune biomarkers and establishing a triple negative phenotype in gynecologic cancers.Semantic proximity Read ↗

Identification of molecular targets in vulvar cancers.Semantic proximity Read ↗

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers V: Recommendations on the Use of Immunohistochemical and Molecular Biomarkers in Penile Cancer.Semantic proximity Read ↗

Biomarkers in bladder cancerSemantic proximity Read ↗

Differential diagnosis of serous papillary carcinoma of the gynaecological tract and basal breast carcinoma: an immunohistochemical approach.Semantic proximity Read ↗

Identification of potential therapeutic targets by molecular profiling of 628 cases of uterine serous carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.